[English] 日本語
Yorodumi- PDB-6w2b: Anomalous bromine signal reveals the position of Br-paroxetine co... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 6w2b | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Anomalous bromine signal reveals the position of Br-paroxetine complexed with the serotonin transporter at the central site | |||||||||
Components |
| |||||||||
Keywords | TRANSPORT PROTEIN / antidepressant / complex / transporter / antibody | |||||||||
| Function / homology | Function and homology informationnegative regulation of cerebellar granule cell precursor proliferation / regulation of thalamus size / Serotonin clearance from the synaptic cleft / positive regulation of serotonin secretion / serotonergic synapse / negative regulation of synaptic transmission, dopaminergic / cocaine binding / serotonin:sodium:chloride symporter activity / cellular response to cGMP / enteric nervous system development ...negative regulation of cerebellar granule cell precursor proliferation / regulation of thalamus size / Serotonin clearance from the synaptic cleft / positive regulation of serotonin secretion / serotonergic synapse / negative regulation of synaptic transmission, dopaminergic / cocaine binding / serotonin:sodium:chloride symporter activity / cellular response to cGMP / enteric nervous system development / negative regulation of organ growth / sodium ion binding / neurotransmitter transmembrane transporter activity / serotonin uptake / vasoconstriction / monoamine transmembrane transporter activity / monoamine transport / serotonin binding / brain morphogenesis / syntaxin-1 binding / antiporter activity / negative regulation of neuron differentiation / male mating behavior / neurotransmitter transport / nitric-oxide synthase binding / amino acid transport / conditioned place preference / membrane depolarization / monoatomic cation channel activity / behavioral response to cocaine / positive regulation of cell cycle / cellular response to retinoic acid / response to nutrient / endomembrane system / sodium ion transmembrane transport / circadian rhythm / response to toxic substance / platelet aggregation / memory / integrin binding / actin filament binding / response to estradiol / presynaptic membrane / postsynaptic membrane / response to hypoxia / neuron projection / endosome membrane / membrane raft / response to xenobiotic stimulus / focal adhesion / synapse / positive regulation of gene expression / identical protein binding / plasma membrane Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human)![]() | |||||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 4.7 Å | |||||||||
Authors | Coleman, J.A. / Navratna, V. / Yang, D. | |||||||||
| Funding support | United States, 2items
| |||||||||
Citation | Journal: Elife / Year: 2020Title: Chemical and structural investigation of the paroxetine-human serotonin transporter complex. Authors: Jonathan A Coleman / Vikas Navratna / Daniele Antermite / Dongxue Yang / James A Bull / Eric Gouaux / ![]() Abstract: Antidepressants target the serotonin transporter (SERT) by inhibiting serotonin reuptake. Structural and biochemical studies aiming to understand binding of small-molecules to conformationally ...Antidepressants target the serotonin transporter (SERT) by inhibiting serotonin reuptake. Structural and biochemical studies aiming to understand binding of small-molecules to conformationally dynamic transporters like SERT often require thermostabilizing mutations and antibodies to stabilize a specific conformation, leading to questions about relationships of these structures to the bonafide conformation and inhibitor binding poses of wild-type transporter. To address these concerns, we determined the structures of ∆N72/∆C13 and ts2-inactive SERT bound to paroxetine analogues using single-particle cryo-EM and x-ray crystallography, respectively. We synthesized enantiopure analogues of paroxetine containing either bromine or iodine instead of fluorine. We exploited the anomalous scattering of bromine and iodine to define the pose of these inhibitors and investigated inhibitor binding to Asn177 mutants of ts2-active SERT. These studies provide mutually consistent insights into how paroxetine and its analogues bind to the central substrate-binding site of SERT, stabilize the outward-open conformation, and inhibit serotonin transport. | |||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 6w2b.cif.gz | 224.8 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb6w2b.ent.gz | 161.9 KB | Display | PDB format |
| PDBx/mmJSON format | 6w2b.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 6w2b_validation.pdf.gz | 644.2 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 6w2b_full_validation.pdf.gz | 659 KB | Display | |
| Data in XML | 6w2b_validation.xml.gz | 23 KB | Display | |
| Data in CIF | 6w2b_validation.cif.gz | 33.8 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/w2/6w2b ftp://data.pdbj.org/pub/pdb/validation_reports/w2/6w2b | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 6vrhC ![]() 6vrkC ![]() 6vrlC ![]() 6w2cC ![]() 6awnS S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 61703.789 Da / Num. of mol.: 1 / Fragment: UNP residues 76-618 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: SLC6A4, HTT, SERT / Cell line (production host): Hek293 GnTi- / Production host: Homo sapiens (human) / References: UniProt: P31645 |
|---|---|
| #2: Antibody | Mass: 24853.619 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() |
| #3: Antibody | Mass: 23718.217 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() |
| #4: Sugar | ChemComp-NAG / |
| #5: Chemical | ChemComp-RFS / |
| Has ligand of interest | Y |
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 3.28 Å3/Da / Density % sol: 62.52 % |
|---|---|
| Crystal grow | Temperature: 277 K / Method: vapor diffusion, hanging drop Details: 50 mM Tris, pH 8.5, 20 mM sodium sulfate, 20 mM lithium chloride, 36% PEG400, 0.5% 6-aminohexanoic acid |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 24-ID-C / Wavelength: 0.9184 Å |
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Jun 30, 2019 |
| Radiation | Monochromator: cryo-cooled double crystal Si(111) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.9184 Å / Relative weight: 1 |
| Reflection | Resolution: 4.69→30 Å / Num. obs: 14667 / % possible obs: 99.2 % / Redundancy: 6.8 % / Biso Wilson estimate: 330.18 Å2 / CC1/2: 0.99 / Rmerge(I) obs: 0.136 / Net I/σ(I): 5.51 |
| Reflection shell | Resolution: 4.69→4.82 Å / Rmerge(I) obs: 0.3393 / Num. unique obs: 1130 / CC1/2: 0.165 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: PDB entry 6AWN Resolution: 4.7→29.76 Å / SU ML: 0.9316 / Cross valid method: FREE R-VALUE / σ(F): 1.34 / Phase error: 43.3396 Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
| ||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 362.07 Å2 | ||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 4.7→29.76 Å
| ||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
United States, 2items
Citation


















PDBj









